BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35053585)

  • 1. Predictors for Adherence to Treatment Strategies in Elderly HNSCC Patients.
    Graessle R; Stromberger C; Heiland M; Doll C; Hofmann VM; Klinghammer K; Tinhofer I; Olze H; Beck M; Arens P; Dommerich S; Piwonski I; Coordes A
    Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subgroup Analysis of Overall Survival among Smoking and Non-Smoking Elderly Patients with HNSCC.
    Graessle R; Stromberger C; Beck M; Heiland M; Hofmann VM; Olze H; Dommerich S; Gauger U; Piwonski I; Coordes A
    Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Factors Predict Oncological Outcome in Older Patients With Head and Neck Cancer Undergoing Chemoradiation Treatment.
    Stromberger C; Yedikat B; Coordes A; Tinhofer I; Kalinauskaite G; Budach V; Zschaeck S; Raguse JD; Kofla G; Heiland M; Stsefanenka A; Beck-Broichsitter B; Dommerich S; Senger C; Beck M
    Front Oncol; 2020; 10():566318. PubMed ID: 33708616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of comorbidity in 9388 head and neck cancer patients: a national cohort study from the DAHANCA database.
    Bøje CR; Dalton SO; Primdahl H; Kristensen CA; Andersen E; Johansen J; Andersen LJ; Overgaard J
    Radiother Oncol; 2014 Jan; 110(1):91-7. PubMed ID: 24412015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curative-Intent Aggressive Treatment Improves Survival in Elderly Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma and High Comorbidity Index.
    Chen JH; Yen YC; Yang HC; Liu SH; Yuan SP; Wu LL; Lee FP; Lin KC; Lai MT; Wu CC; Chen TM; Chang CL; Chow JM; Ding YF; Wu SY
    Medicine (Baltimore); 2016 Apr; 95(14):e3268. PubMed ID: 27057882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Outcomes in Elderly Patients Treated for Oral Cavity Squamous Cell Carcinoma.
    Chen JJ; Shah JL; Harris JP; Bui TT; Schaberg K; Kong CS; Kaplan MJ; Divi V; Schoppy D; Le QT; Hara WY
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):775-783. PubMed ID: 28602409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of primary and adjuvant radiotherapy for cutaneous squamous cell carcinomas of the head-and-neck region in the elderly.
    Haehl E; Rühle A; Klink R; Kalckreuth T; Sprave T; Gkika E; Zamboglou C; Meiß F; Grosu AL; Nicolay NH
    Radiat Oncol; 2021 Jun; 16(1):105. PubMed ID: 34118984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival Patterns in Elderly Head and Neck Squamous Cell Carcinoma Patients Treated With Definitive Radiation Therapy.
    Sommers LW; Steenbakkers RJHM; Bijl HP; Vemer-van den Hoek JGM; Roodenburg JLN; Oosting SF; Halmos GB; de Rooij SE; Langendijk JA
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):793-801. PubMed ID: 28476434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma.
    Cacicedo J; Fernandez I; Del Hoyo O; Navarro A; Gomez-Iturriaga A; Pijoan JI; Martinez-Indart L; Escudero J; Gomez-Suarez J; de Zarate RO; Perez JF; Bilbao P; Rades D
    Clin Transl Oncol; 2017 Nov; 19(11):1337-1349. PubMed ID: 28540535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence of head and neck squamous cell carcinoma patients to tumor board recommendations.
    Rangabashyam MS; Lee SY; Tan SY; Mueller S; Sultana R; Ho J; Skanthakumar T; Tan NC; Tan HK; Soo KC; Iyer NG
    Cancer Med; 2020 Jul; 9(14):5124-5133. PubMed ID: 32472749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of comorbidity on outcome in 12 623 Danish head and neck cancer patients: a population based study from the DAHANCA database.
    Bøje CR; Dalton SO; Grønborg TK; Primdahl H; Kristensen CA; Andersen E; Johansen J; Andersen LJ; Overgaard J
    Acta Oncol; 2013 Feb; 52(2):285-93. PubMed ID: 23320773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elderly patients affected by head and neck squamous cell carcinoma unfit for standard curative treatment: Is de-intensified, hypofractionated radiotherapy a feasible strategy?
    Bonomo P; Desideri I; Loi M; Lo Russo M; Olmetto E; Maragna V; Francolini G; Delli Paoli C; Grassi R; Pezzulla D; Greto D; Meattini I; Livi L
    Oral Oncol; 2017 Nov; 74():142-147. PubMed ID: 29103743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life as a survival predictor for patients with advanced head and neck carcinoma treated with radiotherapy.
    Fang FM; Liu YT; Tang Y; Wang CJ; Ko SF
    Cancer; 2004 Jan; 100(2):425-32. PubMed ID: 14716781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Karnofsky performance status predicts overall survival, cancer-specific survival, and progression-free survival following radical cystectomy for urothelial carcinoma.
    Evers PD; Logan JE; Sills V; Chin AI
    World J Urol; 2014 Apr; 32(2):385-91. PubMed ID: 23756991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Locoregionally recurrent head and neck squamous cell carcinoma: incidence, survival, prognostic factors, and treatment outcomes.
    Chang JH; Wu CC; Yuan KS; Wu ATH; Wu SY
    Oncotarget; 2017 Aug; 8(33):55600-55612. PubMed ID: 28903447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comorbidity and KPS are independent prognostic factors in stage I non-small-cell lung cancer.
    Firat S; Bousamra M; Gore E; Byhardt RW
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):1047-57. PubMed ID: 11958901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comorbidity and performance status as independent prognostic factors in patients with head and neck squamous cell carcinoma.
    Wang JR; Habbous S; Espin-Garcia O; Chen D; Huang SH; Simpson C; Xu W; Liu FF; Brown DH; Gilbert RW; Gullane PJ; Irish JC; Goldstein DP; Liu G
    Head Neck; 2016 May; 38(5):736-42. PubMed ID: 25521753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noncancer health events as a leading cause of competing mortality in advanced head and neck cancer.
    Kwon M; Roh JL; Song J; Lee SW; Kim SB; Choi SH; Nam SY; Kim SY
    Ann Oncol; 2014 Jun; 25(6):1208-14. PubMed ID: 24669018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Head and neck squamous cell carcinoma in patients aged > or = 80 years: patterns of care and survival.
    Italiano A; Ortholan C; Dassonville O; Poissonnet G; Thariat J; Benezery K; Vallicioni J; Peyrade F; Marcy PY; Bensadoun RJ
    Cancer; 2008 Dec; 113(11):3160-8. PubMed ID: 18932260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of comorbidity on survival for locally advanced head and neck cancer patients treated by radiotherapy or radiotherapy plus chemotherapy.
    Liu CT; Chiu TJ; Huang TL; Chien CY; Fang FM
    Chang Gung Med J; 2010; 33(3):283-91. PubMed ID: 20584506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.